A review of mitotane in the management of adrenocortical cancer.

Jaydira Del Rivero Tobias Else Julie Hallanger-Johnson Katja Kiseljak-VassiliadesNitya RajDiane L ReidySandy SrinivasJill GilbertAnand VaidyaEmily AboujaoudeIrina Bancos Antonio Tito Fojo

Published in: The oncologist (2024)

When used carefully and thoughtfully, especially in patients with hormonal excess, mitotane is an important component of the treatment armamentarium for ACC.

Keyphrases

papillary thyroid
squamous cell
polycystic ovary syndrome
adipose tissue
combination therapy
insulin resistance
replacement therapy